Skip to Main content Skip to Navigation
Journal articles

Multimorbidity medications and poor asthma prognosis

Abstract : Multimedication related to multimorbidity is common in the elderly with asthma. We aimed at comprehensively characterising medications used by elderly women and assessing how multimedication impacts on asthma prognosis.We performed network-based analyses on drug administrative databases to visualise the prevalence of drug classes and their interconnections among 17 458 elderly women from the Asthma-E3N study, including 4328 women with asthma. Asthma groups sharing similar medication profiles were identified by a clustering method relying on all medications and were studied in association with adverse asthma events (uncontrolled asthma, attacks/exacerbations and poor asthma-related quality of life).The network-based analysis showed more multimedication in women with asthma than in those without asthma. The clustering method identified three multimedication profiles in asthma: "Few multimorbidity-related medications" (43.5%), "Predominantly allergic multimorbidity-related medications" (32.8%) and "Predominantly metabolic multimorbidity-related medications" (23.7%). Compared with women belonging to the "Few multimorbidity-related medications" profile, women belonging to the two other profiles had an increased risk of uncontrolled asthma and asthma attacks/exacerbations, and had lower asthma-related quality of life.The integrative data-driven approach on drug administrative databases identified specific multimorbidity-related medication profiles that were associated with poor asthma prognosis. These findings support the importance of multimorbidity in the unmet needs in asthma management.
Complete list of metadatas

Cited literature [42 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01801959
Contributor : Beatrice Faraldo <>
Submitted on : Monday, May 28, 2018 - 6:31:41 PM
Last modification on : Wednesday, September 16, 2020 - 5:29:03 PM
Long-term archiving on: : Wednesday, August 29, 2018 - 3:20:39 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Citation

Sébastien Chanoine, Margaux Sanchez, Isabelle Pin, Sofia Temam, Nicole Le Moual, et al.. Multimorbidity medications and poor asthma prognosis. European Respiratory Journal, European Respiratory Society, 2018, 51 (4), Print 2018 Apr. ⟨10.1183/13993003.02114-2017⟩. ⟨inserm-01801959⟩

Share

Metrics

Record views

423